An ω-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 315,771 · see citing works

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780 · see citing works

Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies

Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706 · see citing works

Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA

Goldstein, J. L., Schrott, H. G., Hazzard, W. R., Bierman, E. L., & Motulsky, A. G. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107332 · Cited by 1,444 · see citing works

Paraoxonase and Atherosclerosis

Durrington, P. N., Mackness, B., & Mackness, M. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.4.473 · Cited by 821 · see citing works

Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus

Mackness, M., Harty, D. W. S., Bhatnagar, D., Winocour, P. H., Arrol, S., Ishola, M., & Durrington, P. N. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90215-o · Cited by 492 · see citing works

Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins.

Miller, N. E., Hammett, F., Saltissi, S., Rao, S., Zeller, H., Coltart, J., & Lewis, B. (1981) · BMJ · doi:10.1136/bmj.282.6278.1741 · Cited by 482 · see citing works

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.

Garin, M. C., James, R. W., Dussoix, P., Blanché, H., Passa, P., Froguel, P., & Ruiz, J. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119134 · Cited by 476 · see citing works

Hyperlipidemia in Coronary Heart Disease

Goldstein, J. L., HAzzmm, W. R., ScinoTT, H. G., Bierman, E. L., Levinski, M. J., & Campbell, E. D. (1973) · Cited by 471 · see citing works

Human Serum Paraoxonases (PON1) Q and R Selectively Decrease Lipid Peroxides in Human Coronary and Carotid Atherosclerotic Lesions

Aviram, M., Hardak, E., Vaya, J., Mahmood, S., Milo, S., Hoffman, A., Billicke, S., Draganov, D. I., & Rosenblat, M. (2000) · Circulation · doi:10.1161/01.cir.101.21.2510 · Cited by 460 · see citing works

Low-density lipoprotein subclass patterns and risk of myocardial infarction

Austin, M. A. (1988) · JAMA · doi:10.1001/jama.260.13.1917 · Cited by 414 · see citing works

HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men.

Salonen, J. T., Salonen, R. M., Seppänen, K., Rauramaa, R., & Tuomilehto, J. O. (1991) · Circulation · doi:10.1161/01.cir.84.1.129 · Cited by 360 · see citing works

Identification of a distinct human high‐density lipoprotein subspecies defined by a lipoprotein‐associated protein, K‐45

Blatter, M.-C., James, R. W., Messmer, S., Barja, F., & Pometta, D. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17620.x · Cited by 347 · see citing works

Safety and Efficacy of Omacor in Severe Hypertriglyceridemia

Harris, W. S., Ginsberg, H. N., Arunakul, N., Shachter, N. S., Windsor, S. L., Adams, M., Berglund, L., & Osmundsen, K. (1997) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679700400511 · Cited by 306 · see citing works

Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia

Brunzell, J. D., Albers, J. J., Chait, A., Grundy, S. M., Groszek, E., & McDonald, G. (1983) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38008-1 · Cited by 304 · see citing works

Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.

Brinton, E. A., Eisenberg, S., & Breslow, J. L. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.5.707 · Cited by 265 · see citing works

Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia.

Austin, M. A., Brunzell, J. D., Fitch, W. L., & Krauss, R. M. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.4.520 · Cited by 262 · see citing works

Safety and efficacy of Omacor in severe hypertriglyceridemia

Harris, W. S., Ginsberg, H. N., Arunakul, N., Shachter, N. S., Windsor, S. L., Adams, M., Berglund, L., & Osmundsen, K. (1997) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199710000-00011 · Cited by 252 · see citing works

Enzymatically Active Paraoxonase-1 Is Located at the External Membrane of Producing Cells and Released by a High Affinity, Saturable, Desorption Mechanism

Deakin, S., Leviev, I., Gomaraschi, M., Calabresi, L., Franceschini, G., & James, R. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107440200 · Cited by 251 · see citing works

Lipoprotein Oxidation and Progression of Carotid Atherosclerosis

Salonen, J. T., ̈nen, K. N., Salonen, R. M., Porkkala-Sarataho, E., Tuomainen, T., Diczfalusy, U., & Björkhem, I. (1997) · Circulation · doi:10.1161/01.cir.95.4.840 · Cited by 241 · see citing works

Effect of Simvastatin Therapy on Paraoxonase Activity and Related Lipoproteins in Familial Hypercholesterolemic Patients

Tomàs, M., Sentı́, M., García-Faria, F., Vila, J., Torrents, A., Covas, M. I., & Marrugat, J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.9.2113 · Cited by 223 · see citing works

Smoking Is Associated With Reduced Serum Paraoxonase Activity and Concentration in Patients With Coronary Artery Disease

James, R. W., Leviev, I., & Righetti, A. (2000) · Circulation · doi:10.1161/01.cir.101.19.2252 · Cited by 216 · see citing works

Triglycerides Are Major Determinants of Cholesterol Esterification/Transfer and HDL Remodeling in Human Plasma

Murakami, T., Michelagnoli, S., Longhi, R., Gianfranceschi, G., Pazzucconi, F., Calabresi, L., Sirtori, C. R., & Franceschini, G. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.1819 · Cited by 201 · see citing works

Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men

van der Gaag, M. S., van Tol, A., Scheek, L. M., James, R. W., Rob Urgert, B., Schaafsma, G., & Hendriks, H. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00243-9 · Cited by 197 · see citing works

Vitamin C and E Intake Is Associated With Increased Paraoxonase Activity

Jarvik, G. P., Tsai, N. T., McKinstry, L. A., Wani, R., Brophy, V. H., Richter, R. J., Schellenberg, G. D., Heagerty, P. J., Hatsukami, T. S., & Furlong, C. E. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000027101.40323.3a · Cited by 190 · see citing works

Associations of HDL 2 and HDL 3 Subfractions With Ischemic Heart Disease in Men

Lamarche, B., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Després, J. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.6.1098 · Cited by 170 · see citing works

Effect of fish oil on lipoproteins, lecithin:cholesterol acyltransferase, and lipid transfer protein activity in humans.

Abbey, M., Clifton, P. M., Kestin, M., Belling, B., & Nestel, P. J. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.1.85 · Cited by 162 · see citing works

Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia

Durrington, P. N., Mackness, M., Bhatnagar, D., Julier, K., Prais, H., Arrol, S., Morgan, J., & Wood, G. N. I. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00003-3 · Cited by 143 · see citing works

Reduced Postprandial Serum Paraoxonase Activity After a Meal Rich in Used Cooking Fat

Sutherland, W. H. F., Walker, R. J., de Jong, S. A., van Rij, A. M., Phillips, V., & Walker, H. L. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.5.1340 · Cited by 138 · see citing works

Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations

Garin, M. C., Abbott, C. A., Messmer, S., Mackness, M., Durrington, P. N., Pometta, D., & James, R. W. (1994) · Biochemical Journal · doi:10.1042/bj3040549 · Cited by 129 · see citing works

Combination Drug Therapy for Familial Combined Hyperlipidemia

East, C. A., Bilheimer, D. W., & Grundy, S. M. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-1-25 · Cited by 118 · see citing works

Increased Cholesterol Efflux Potential of Sera From ApoA-I Milano Carriers and Transgenic Mice

Franceschini, G., Calabresi, L., Chiesa, G., Parolini, C., Sirtori, C. R., Canavesi, M., & Bernini, F. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.5.1257 · Cited by 117 · see citing works

Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses

Calabresi, L., Donati, D., Pazzucconi, F., Sirtori, C. R., & Franceschini, G. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00267-1 · Cited by 104 · see citing works

Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability

Bredie, S. J. H., de Bruin, T. W., Demacker, P. N. M., Kastelein, J. J. P., & Stalenhoef, A. F. H. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80552-9 · Cited by 104 · see citing works

Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia.

Hokanson, J. E., Austin, M. A., Zambon, A., & Brunzell, J. D. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.3.427 · Cited by 101 · see citing works

Associations of the HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies.

Sweetnam, P. M., Bolton, C. H., Yarnell, J. W., Bainton, D., Baker, I. A., Elwood, P. C., & Miller, N. E. (1994) · Circulation · doi:10.1161/01.cir.90.2.769 · Cited by 98 · see citing works

Lipid, lipoprotein, and hemostatic effects of fish vs fish-oil n − 3 fatty acids in mildly hyperlipidemic males

Cobiac, L., Clifton, P. M., Abbey, M., Belling, G. B., & Nestel, P. (1991) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.5.1210 · Cited by 89 · see citing works

HDL, HDL_2, and HDL_3 subfractions, and the risk of acute myocardial infarction

SALONEN, J. T., Salonen, R. M., Seppänen, K., Rauramaa, R., & Tuomilehto, J. (1991) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 78 · see citing works

Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states

James, R. W., Blatter, M.-C., Calabresi, L., Miccoli, R., von Eckardstein, A., Tilly-Kiesi, M., Taskinen, M., Assmann, G., & Franceschini, G. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00058-6 · Cited by 66 · see citing works

Pravastatin effectively lowers LDL cholesterol in familial combined hyperlipidemia without changing LDL subclass pattern.

Franceschini, G., Cassinotti, M., Vecchio, G., Gianfranceschi, G., Pazzucconi, F., Murakami, T., Sirtori, M., D'Acquarica, A. L., & Sirtori, C. R. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1569 · Cited by 64 · see citing works

Association Between Carotid Intima-Media Thickness and Low-Density Lipoprotein Size and Susceptibility of Low-Density Lipoprotein to Oxidation in Asymptomatic Members of Familial Combined Hyperlipidemia Families

Liu, M., Ylitalo, K., Nuotio, I. O., Salonen, R., Salonen, J. T., & Taskinen, M. (2002) · Stroke · doi:10.1161/01.str.0000014924.29238.e1 · Cited by 61 · see citing works

n−3 Polyunsaturated fatty acids raise low-density lipoproteins, high-density lipoprotein 2, and plasminogen-activator inhibitor in healthy young men

Fumeron, F., Brigant, L., Ollivier, V., de Prost, D., Driss, F., Darcet, P., Bard, J., Parra, H., Fruchart, J., & Apfelbaum, M. (1991) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.1.118 · Cited by 61 · see citing works

The effects of ω3 and ω6 fatty acid-enriched diets on plasma lipoproteins and apoproteins in familial combined hyperlipidemia

Failor, R. A., Childs, M. T., & Bierman, E. L. (1988) · Metabolism · doi:10.1016/0026-0495(88)90061-3 · Cited by 53 · see citing works

Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women

Sutherland, W. H. F., Manning, P. J., de Jong, S. A., Allum, A. R., Jones, S., & Williams, S. (2001) · Metabolism · doi:10.1053/meta.2001.20201 · Cited by 47 · see citing works

Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: Additive effects of combination treatment on lipid regulation

Zambón, D., Ros, E., Rodrı́guez-Villar, C., Laguna, J. C., Vázquez, M., Sanllehy, C., Casals, E., Sol, J. M., & Hernández, G. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90009-4 · Cited by 45 · see citing works

Inhibition of lecithin:cholesterol acyltransferase activity by synthetic phosphatidylcholine species containing eicosapentaenoic acid or docosahexaenoic acid in the sn-2 position.

Parks, J. S., Thuren, T., & Schmitt, J. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41513-5 · Cited by 45 · see citing works

Effects of storage on the distribution of high density lipoprotein subfractions in human sera

Franceschini, G., Tosi, C., Moreno, Y., & Sirtori, C. R. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34264-4 · Cited by 40 · see citing works

Reduced HDL2 levels in myocardial infarction patients without risk factors for atherosclerosis

Franceschini, G., Bondioli, A., Granata, D., Mercuri, V., Negri, M., Tosi, C., & Sirtori, C. R. (1987) · Atherosclerosis · doi:10.1016/0021-9150(87)90200-0 · Cited by 36 · see citing works

ω-3 Fatty acids selectively raise high-density lipoprotein 2 levels in healthy volunteers

Franceschini, G., Calabresi, L., MADERNA, P., Galli, C., Gianfranceschi, G., & Sirtori, C. R. (1991) · Metabolism · doi:10.1016/0026-0495(91)90029-v · Cited by 29 · see citing works

Effect of marine lipids on cholesteryl ester transfer and lipoprotein composition in patients with hypercholesterolemia.

Bagdade, J. D., Ritter, M. C., Davidson, M. H., & Subbaiah, P. V. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.10.1146 · Cited by 26 · see citing works

Susceptibility of LDL to oxidation in vitro and antioxidant capacity in familial combined hyperlipidemia: comparison of patients with different lipid phenotypes

Liu, M.-L., Ylitalo, K., Vakkilainen, J., Nuotio, I., Valkonen, M., Lahdenperä, S., Viikari, J., & Taskinen, M.-R. (2002) · Annals of Medicine · doi:10.1080/078538902317338643 · Cited by 23 · see citing works

Significant increase of high-density lipoprotein2-cholesterol under prolonged simvastatin treatment

Neuman, M. P., Neuman, H. R., & Neuman, J. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90202-e · Cited by 20 · see citing works

Effects of fish oil concentrate on lipoproteins and apolipoproteins in familial combined hyperlipidemia

Tat�, F., Keller, C., & Wolfram, G. (1993) · Journal of Molecular Medicine · doi:10.1007/bf00184734 · Cited by 14 · see citing works

Apolipoprotein A-I Milano: sex-related differences in the concentration and composition of apoA-I- and apoB-containing lipoprotein particles.

Bekaert, E. D., Alaupovic, P., Knight‐Gibson, C., Franceschini, G., & Sirtori, C. R. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41325-2 · Cited by 10 · see citing works

Evidence against alterations in Lecithin:cholesterol acyltransferase (LCAT) activity in Familial combined hyperlipidemia

Ribalta, J., Ville, A. E. L., Vallvé, J.-C., Girona, J., & Masana, L. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00043-4 · Cited by 3 · see citing works

A Systemic Review of the Roles of n-3 Fatty Acids in Health and Disease

Riediger, N. D., Othman, R. A., Suh, M., & Moghadasian, M. H. (2009) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2008.12.022 · Cited by 694 · see citing works

Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease

Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub3 · Cited by 631 · see citing works

Modulation of paraoxonase (PON1) activity

Costa, L. G., Vitalone, A., Cole, T. B., & Furlong, C. E. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.08.027 · Cited by 487 · see citing works

Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease

Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub4 · Cited by 409 · see citing works

Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease

Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., Summerbell, C. D., Worthington, H. V., Song, F., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub5 · Cited by 295 · see citing works

Omega 3 fatty acids for prevention and treatment of cardiovascular disease

Hooper, L., Harrison, R. A., Summerbell, C. D., Moore, H., Worthington, H. V., Ness, A., Capps, N., Davey Smith, G., Riemersma, R., & Ebrahim, S. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub2 · Cited by 264 · see citing works

Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications

Bays, H. E., Tighe, A. P., D, R. S. M., & Davidson, M. H. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.3.391 · Cited by 263 · see citing works

Genetic causes of high and low serum HDL-cholesterol

Weissglas‐Volkov, D., & Pajukanta, P. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r004739 · Cited by 219 · see citing works

Antiatherosclerotic and Antithrombotic Effects of Omega-3 Fatty Acids

Robinson, J. G., & Stone, N. J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.026 · Cited by 207 · see citing works

Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: The hunt goes on

Costa, L. G., Giordano, G., & Furlong, C. E. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.11.008 · Cited by 188 · see citing works

Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review

Oscarsson, J., & Hurt-Camejo, E. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0541-3 · Cited by 158 · see citing works

Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters

Shearer, G. C., Harris, W. S., Pedersen, T. L., & Newman, J. W. I. (2009) · Journal of Lipid Research · doi:10.1194/m900193-jlr200 · Cited by 152 · see citing works

The Role of Paraoxonase 1 Activity in Cardiovascular Disease

Mackness, M., Durrington, P. N., & Mackness, B. (2004) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200404040-00002 · Cited by 142 · see citing works

Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences

Aviram, M., & Rosenblat, M. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000174398.84185.0f · Cited by 140 · see citing works

Purified Eicosapentaenoic Acid Reduces Small Dense LDL, Remnant Lipoprotein Particles, and C-Reactive Protein in Metabolic Syndrome

Satoh, N., Shimatsu, A., Kotani, K., Sakane, N., Yamada, K., Suganami, T., Kuzuya, H., & Ogawa, Y. (2006) · Diabetes Care · doi:10.2337/dc06-1179 · Cited by 137 · see citing works

Role of Prescription Omega‐3 Fatty Acids in the Treatment of Hypertriglyceridemia

McKenney, J. M., & Sica, D. A. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.5.715 · Cited by 131 · see citing works

Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta‐analysis of randomised placebo‐control human clinical trials

AbuMweis, S., Jew, S., Tayyem, R., & Agraib, L. (2018) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12493 · Cited by 122 · see citing works

Clinical Overview of Omacor: A Concentrated Formulation of Omega-3 Polyunsaturated Fatty Acids

Bays, H. E. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.029 · Cited by 121 · see citing works

Omega-3 Polyunsaturated Fatty Acids in Physical Performance Optimization

Mickleborough, T. D. (2013) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.23.1.83 · Cited by 116 · see citing works

Variation in paraoxonase-1 activity and atherosclerosis

Soran, H., Younis, N. N., Charlton-Menys, V., & Durrington, P. N. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832ec141 · Cited by 116 · see citing works

Impact of foods enriched with<i>n</i>-3 long-chain polyunsaturated fatty acids on erythrocyte<i>n</i>-3 levels and cardiovascular risk factors

Murphy, K. J., Meyer, B. J., Mori, T. A., Burke, V., Mansour, J., Patch, C. S., Tapsell, L. C., Noakes, M., Clifton, P. A., Barden, A., et al. (2007) · British Journal Of Nutrition · doi:10.1017/s000711450747252x · Cited by 110 · see citing works

Low n-6:n-3 fatty acid ratio, with fish- or flaxseed oil, in a high fat diet improves plasma lipids and beneficially alters tissue fatty acid composition in mice

Riediger, N. D., Othman, R. A., Fitz, E., Pierce, G. N., Suh, M., & Moghadasian, M. H. (2008) · European Journal of Nutrition · doi:10.1007/s00394-008-0709-8 · Cited by 110 · see citing works

Paraoxonase-1 as a Regulator of Glucose and Lipid Homeostasis: Impact on the Onset and Progression of Metabolic Disorders

Meneses, M. J., Silvestre, R. D., Sousa‐Lima, I., & Macedo, M. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20164049 · Cited by 114 · see citing works

The “Good Cholesterol”

Toth, P. P. (2005) · Circulation · doi:10.1161/01.cir.0000154555.07002.ca · Cited by 106 · see citing works

A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels

von Schacky, C. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.251 · Cited by 103 · see citing works

Influence of dietary carbohydrate and fat on LDL and HDL particle distributions

Siri, P. W., & Krauss, R. M. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0062-9 · Cited by 97 · see citing works

Administration of high dose eicosapentaenoic acid enhances anti-inflammatory properties of high-density lipoprotein in Japanese patients with dyslipidemia

Tanaka, N. K., Ishida, T., Nagao, M., Mori, T., Monguchi, T., Sasaki, M., Mori, K., Kondo, K., Nakajima, H., Honjo, T., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.10.011 · Cited by 92 · see citing works

Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date.

Gaddi, A. V., Cicero, A. F. G., Odoo, F. O., Poli, A. A., & Paoletti, R. (2007) · PubMed Central · Cited by 92 · see citing works

Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia

Skulas-Ray, A. C., West, S. G., Davidson, M. H., & Kris-Etherton, P. M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.7.1237 · Cited by 91 · see citing works

Flaxseed Oil Supplementation Does Not Affect Plasma Lipoprotein Concentration or Particle Size in Human Subjects

Harper, C. R., Edwards, M. C., & Jacobson, T. A. (2006) · Journal of Nutrition · doi:10.1093/jn/136.11.2844 · Cited by 89 · see citing works

Food Insecurity, Health and Nutritional Status among Sample of Palm-plantation Households in Malaysia

Mohamadpour, M., Sharif, Z., & Keysami, M. A. (2012) · Journal of Health Population and Nutrition · doi:10.3329/jhpn.v30i3.12292 · Cited by 81 · see citing works

Functional LCAT is not required for macrophage cholesterol efflux to human serum

Calabresi, L., Favari, E., Moleri, E., Adorni, M. P., Pedrelli, M., Costa, S., Jessup, W., Gelissen, I. C., Kovanen, P. T., Bernini, F., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.08.038 · Cited by 72 · see citing works

Dietary Almonds Increase Serum HDL Cholesterol in Coronary Artery Disease Patients in a Randomized Controlled Trial

Jamshed, H., Sultan, F. A. T., Iqbal, R., & Gilani, A. H. (2015) · Journal of Nutrition · doi:10.3945/jn.114.207944 · Cited by 67 · see citing works

Effects of fenofibrate and simvastatin on HDL-related biomarkers in low-HDL patients

Franceschini, G., Calabresi, L., Colombo, C., Favari, E., Bernini, F., & Sirtori, C. R. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.10.017 · Cited by 66 · see citing works

Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols

Demonty, I., Chan, Y., Pelled, D., & Jones, P. J. H. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.6.1534 · Cited by 64 · see citing works

Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia

Han, E., Yun, Y., Kim, G., Lee, Y., Wang, H. J., Lee, B., Soo, B., Kim, B. S., & Kang, E. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154683 · Cited by 62 · see citing works

Docosahexaenoic acid at the sn-2 position of structured triacylglycerols improved n-3 polyunsaturated fatty acid assimilation in tissues of hamsters

Bandarra, N. M., Lopes, P. A., Martins, S. V., Ferreira, J., Alfaia, C. M., Rolo, E. A., Correia, J., Pinto, R. M. A., Ramos‐Bueno, R. P., Batista, I., et al. (2016) · Nutrition Research · doi:10.1016/j.nutres.2015.12.015 · Cited by 59 · see citing works

The role of marine n-3 fatty acids in improving cardiovascular health: a review

Nicholson, T., Khademi, H., & Moghadasian, M. H. (2013) · Food & Function · doi:10.1039/c2fo30235g · Cited by 56 · see citing works

FADS1 FADS2 Gene Cluster, PUFA Intake and Blood Lipids in Children: Results from the GINIplus and LISAplus Studies

Standl, M., Lattka, E., Stach, B., Koletzko, S., Bauer, C., Berg, A. V., Berdel, D., Krämer, U., Schaaf, B., Röder, S. W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037780 · Cited by 55 · see citing works

Krill oil reduces plasma triacylglycerol level and improves related lipoprotein particle concentration, fatty acid composition and redox status in healthy young adults - a pilot study

Berge, R. K., Ramsvik, M. S., Bohov, P., Svardal, A., Nordrehaug, J. E., Rostrup, E., Bruheim, I., & Bjørndal, B. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0162-7 · Cited by 51 · see citing works

Transgenic ω-3 PUFA enrichment alters morphology and gene expression profile in adipose tissue of obese mice: Potential role for protectins

White, P. J., Mitchell, P. L., Schwab, M. G., Trottier, J., Kang, J., Barbier, O., & Marette, A. (2015) · Metabolism · doi:10.1016/j.metabol.2015.01.017 · Cited by 51 · see citing works

Omega-3 fatty acids: their beneficial role in cardiovascular health.

Schwalfenberg, G. (2006) · Europe PMC (PubMed Central) · Cited by 51 · see citing works

Beneficial effects of omega-3 fatty acids in the proteome of high-density lipoprotein proteome

Burillo, E., Mateo‐Gállego, R., Cenarro, A., Fiddyment, S., Bea, A. M., Jorge, I., Vázquez, J., & Civeira, F. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-116 · Cited by 48 · see citing works

Moderate doses of EPA and DHA from re-esterified triacylglycerols but not from ethyl-esters lower fasting serum triacylglycerols in statin-treated dyslipidemic subjects: Results from a six month randomized controlled trial

Schuchardt, J. P., Neubronner, J., Kressel, G., Merkel, M., von Schacky, C., & Hahn, A. (2011) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2011.07.006 · Cited by 47 · see citing works

Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction

Zimetti, F., VUONO, S. D., Gomaraschi, M., Adorni, M. P., Favari, E., Ronda, N., Ricci, M. A., Veglia, F., Calabresi, L., & Lupattelli, G. (2017) · Journal of Lipid Research · doi:10.1194/jlr.p076463 · Cited by 47 · see citing works

Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategies

Taghizadeh, E., Esfehani, R. J., Sahebkar, A., Parizadeh, S. M., Rostami, D., Mirinezhad, M., Poursheikhani, A., Ghayour‐Mobarhan, M., & Pasdar, A. (2019) · IUBMB Life · doi:10.1002/iub.2073 · Cited by 45 · see citing works

Responses of LDL and HDL particle size and distribution to omega-3 fatty acid supplementation and aerobic exercise

Wooten, J. S., Biggerstaff, K. D., & Ben‐Ezra, V. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91062.2008 · Cited by 43 · see citing works

Role of polyphenols and polyphenol-rich foods in the modulation of PON1 activity and expression

Martini, D., Bo’, C. D., Porrini, M., Ciappellano, S., & Riso, P. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.06.002 · Cited by 43 · see citing works

Omega-3 Fatty Acids Improve Functionality of High-Density Lipoprotein in Individuals With High Cardiovascular Risk: A Randomized, Parallel, Controlled and Double-Blind Clinical Trial

Cartolano, F. D. C., Dias, G. D. F., Miyamoto, S., & Damasceno, N. R. T. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.767535 · Cited by 41 · see citing works

Distinct regulation of plasma LDL cholesterol by eicosapentaenoic acid and docosahexaenoic acid in high fat diet-fed hamsters: Participation of cholesterol ester transfer protein and LDL receptor

Ishida, T., Ohta, M., Nakakuki, M., Kami, H., Uchiyama, R., Kawano, H., Notsu, T., Imada, K., & Shimano, H. (2013) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2013.01.001 · Cited by 41 · see citing works

DEMONSTRATION OF DOCOSAHEXAENOIC ACID AS A BIOAVAILABILITY ENHANCER FOR CYP3A SUBSTRATES: IN VITRO AND IN VIVO EVIDENCE USING CYCLOSPORIN IN RATS

Hirunpanich, V., Katagi, J., Sethabouppha, B., & Sato, H. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.007088 · Cited by 39 · see citing works

Fish oil in the treatment of dyslipidemia

Goldberg, R. B., & Sabharwal, A. K. (2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3282f76728 · Cited by 37 · see citing works

Paraoxonase Activity Following Exercise-Based Cardiac Rehabilitation Program

Goldhammer, E., Ben‐Sira, D., Zaid, G., Biniamini, Y., Maor, I., Lanir, A., & Sagiv, M. S. (2007) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/01.hcr.0000270691.09258.b1 · Cited by 35 · see citing works

Role of Paraoxonase1 in the Regulation of High-Density Lipoprotein Functionality and in Cardiovascular Protection

Khalil, A., Fülöp, T., & Berrougui, H. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7998 · Cited by 36 · see citing works

Integrated transcriptome and phosphoproteome analyses reveal that fads2 is critical for maintaining body LC-PUFA homeostasis

Zhao, Y., Yang, G., Wu, N., Cao, X., & Gao, J. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.103967 · Cited by 34 · see citing works

High-Density Lipoprotein Metabolism and Function in Cardiovascular Diseases: What about Aging and Diet Effects?

Morvaridzadeh, M., Zoubdane, N., Heshmati, J., Alami, M., Berrougui, H., & Khalil, A. (2024) · Nutrients · doi:10.3390/nu16050653 · Cited by 31 · see citing works

The Antioxidant Status Response to Low-Fat and Walnut Paste–Enriched Meat Differs in Volunteers at High Cardiovascular Risk Carrying Different PON-1 Polymorphisms

Sánchez-Muniz, F. J., Canales, A., Nus, M., Bastida, S., Guillén, M., Corella, D., Olmedilla‐Alonso, B., Granado‐Lorencio, F., & Benedı́, J. (2012) · Journal of the American College of Nutrition · doi:10.1080/07315724.2012.10720027 · Cited by 30 · see citing works

Postprandial serum triacylglycerols and oxidative stress in mice after consumption of fish oil, soy oil or olive oil: Possible role for paraoxonase-1 triacylglycerol lipase-like activity

Fuhrman, B., Volkova, N., & Aviram, M. (2006) · Nutrition · doi:10.1016/j.nut.2006.04.012 · Cited by 29 · see citing works

Distinct Influence of Omega-3 Fatty Acids on the Plasma Metabolome of Healthy Older Adults

Xyda, S., Vučković, I., Petterson, X.-M. T., Dasari, S., Lalia, A. Z., Parvizi, M., Macura, S. I., & Lanza, I. R. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz141 · Cited by 28 · see citing works

Modification of High-Density Lipoprotein Functions by Diet and Other Lifestyle Changes: A Systematic Review of Randomized Controlled Trials

Sanllorente, A., Lassale, C. M., Soria-Florido, M. T., Castañer, O., Fitó, M., & Hernáez, Á. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245897 · Cited by 26 · see citing works

Modulatory Effect of Lifestyle-Related, Environmental and Genetic Factors on Paraoxonase-1 Activity: A Review

Kunachowicz, D., Ściskalska, M., & Kepinská, M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20042813 · Cited by 26 · see citing works

Effect of fish oil supplements on serum paraoxonase activity in female patients with rheumatoid arthritis: a double-blind randomized controlled trial.

Ghorbanihaghjo, A., Kolahi, S., Seifirad, S., Rashtchizadeh, N., Argani, H., Hajialilo, M., Khabazi, A., Alizadeh, S., & Bahreini, E. (2012) · PubMed · Cited by 26 · see citing works

Long-chain n-3 fatty acids and classical cardiovascular disease risk factors among the Catalan population

Mayneris‐Perxachs, J., Bondia‐Pons, I., Serra‐Majem, L., Castellote, A. I., & López‐Sabater, M. C. (2009) · Food Chemistry · doi:10.1016/j.foodchem.2009.05.073 · Cited by 24 · see citing works

Dietary omega-3 polyunsaturated fatty acid intake is related to a protective high-density lipoprotein subspecies profile independent of genetic effects: A monozygotic twin pair study

Bogl, L. H., Maranghi, M., Rissanen, A., Kaprio, J. A., Taskinen, M., & Pietiläinen, K. H. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.09.010 · Cited by 22 · see citing works

Small dense low-density lipoprotein-lowering agents

Alizadeh‐Fanalou, S., Nazarizadeh, A., Alian, F., Faraji, P., Sorori, B., & Khosravi, M. (2020) · Biological Chemistry · doi:10.1515/hsz-2019-0426 · Cited by 22 · see citing works

Prospective randomized comparison between omega-3 fatty acid supplements plus simvastatin versus simvastatin alone in Korean patients with mixed dyslipidemia: lipoprotein profiles and heart rate variability

Kim, S.-H., Kim, M.-K., Lee, H.-Y., Kang, H.-J., Kim, Y.-J., & Kim, H.-S. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.195 · Cited by 21 · see citing works

Sources and Health Benefits of Functional Food Components

Shaikh, S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104091 · Cited by 20 · see citing works

Consumption of polyunsaturated fat improves the saturated fatty acid‐mediated impairment of HDL antioxidant potential

Cedó, L., Metso, J., Santos, D., Sánchez‐Quesada, J. L., Julve, J., García‐León, A., Móra, J., Jauhiainen, M., Blanco‐Vaca, F., & Escolá‐Gil, J. C. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500336 · Cited by 20 · see citing works

Serum Paraoxonase 1 Activity Is Associated with Fatty Acid Composition of High Density Lipoprotein

Boshtam, M., Razavi, À. E., Pourfarzam, M., Ani, M., Naderi, G. A., Basati, G., Mansourian, M., Dinani, N. J., Asgary, S., & Abdi, S. (2013) · Disease Markers · doi:10.1155/2013/612035 · Cited by 20 · see citing works

Omega 3 fatty acid supplementation after myocardial infarction: a systematic review and meta-analysis

Popoff, F., Balaciano, G., Bardach, A., Comandé, D., Irazola, V., Catalano, H. N., & Izcovich, A. (2019) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-1086-3 · Cited by 19 · see citing works

The ratio of eicosapentaenoic acid to docosahexaenoic acid as a modulator for the cardio-metabolic effects of omega-3 supplements: A meta-regression of randomized clinical trials

AbuMweis, S. S., Omran, D. A., Al-Shami, I. K., & Jew, S. (2021) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2021.102662 · Cited by 18 · see citing works

The effect of the paraoxonase 1 (PON1) T(−107)C polymorphism on serum PON1 activity in women is dependent on fatty acid intake

dos Santos, F. G., Becker, M. K., Corrêa, V. S., Garcia, D. N., Valle, S. C., Crespo-Ribeiro, J. A., Barros, C. C., & Schneider, A. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.10.008 · Cited by 18 · see citing works

Nutritional And Nutraceutical Considerations For Dyslipidemia

Sirtori, C. R., Anderson, J. W., & Arnoldi, A. (2007) · Future Lipidology · doi:10.2217/17460875.2.3.313 · Cited by 18 · see citing works

Benefits of Omega-3 Fatty Acids Supplementation on Serum Paraoxonase 1 Activity and Lipids Ratios in Polycystic Ovary Syndrome

Mohammadi, E., & Rafraf, M. (2012) · Europe PMC (PubMed Central) · doi:10.5681/hpp.2012.023 · Cited by 16 · see citing works

Bis(4,4′-dimethyl-2,2′-bipyridine)oxidovanadium(IV) Sulfate Dehydrate: Potential Candidate for Controlling Lipid Metabolism?

Francik, R., Kryczyk‐Kozioł, J., Francik, S., Gryboś, R., & Krośniak, M. (2017) · BioMed Research International · doi:10.1155/2017/6950516 · Cited by 16 · see citing works

Determination of the Genotype and Phenotype of Serum Paraoxonase 1 (PON1) Status in a Group of Agricultural and Nonagricultural Workers in the Coquimbo Region, Chile

Zúñiga-Venegas, L. A., Aquea, G., Taborda, M. I., Bernal, G., & Pancetti, F. C. (2015) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2014.982843 · Cited by 16 · see citing works

A Randomized Trial of ω-3 Fatty Acid Supplementation and Circulating Lipoprotein Subclasses in Healthy Older Adults

Moosavi, D., Vučković, I., Kunz, H., & Lanza, I. R. (2022) · Journal of Nutrition · doi:10.1093/jn/nxac084 · Cited by 15 · see citing works

Transgenic n-3 PUFAs enrichment leads to weight loss via modulating neuropeptides in hypothalamus

Ma, S., Ge, Y., Gai, X., Xue, M., Li, N., Kang, J.-X., Wan, J., & Zhang, J. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.11.029 · Cited by 15 · see citing works

A Diet Enriched in Docosahexanoic Acid Exacerbates Brain Parenchymal Extravasation of Apo B Lipoproteins Induced by Chronic Ingestion of Saturated Fats

Pallebage‐Gamarallage, M. M., Lam, V., Takechi, R., Galloway, S., & Mamo, J. C. L. (2011) · International Journal of Vascular Medicine · doi:10.1155/2012/647689 · Cited by 14 · see citing works

Effect of Eicosapentaenoic Acid Supplementation on Paraoxonase 2 Gene Expression in Patients with Type 2 Diabetes Mellitus: a Randomized Double-blind Clinical Trial

Golzari, M. H., Javanbakht, M. H., Ghaedi, E., Mohammadi, H., & Djalali, M. (2019) · Clinical Nutrition Research · doi:10.7762/cnr.2019.8.1.17 · Cited by 14 · see citing works

Alimentación saludable basada en la evidencia

Calañas-Continente, A. (2005) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(05)74649-0 · Cited by 14 · see citing works

Omega-3 fatty acids and exercise: a review of their combined effects on body composition and physical performance

Tiryaki-Sonmez, G., Schoenfeld, B., & Vatansever-Ozen, S. (2011) · Biomedical Human Kinetics · doi:10.2478/v10101-011-0007-4 · Cited by 17 · see citing works

Erythrocyte Membrane Fluidity and Omega-3 Fatty Acid Intake: Current Outlook and Perspectives for a Novel, Nutritionally Modifiable Cardiovascular Risk Factor

Capece, U., Gugliandolo, S., Morciano, C., Avolio, A., Splendore, A., Giuseppe, G. D., Ciccarelli, G., Soldovieri, L., Brunetti, M., Mezza, T., et al. (2024) · Nutrients · doi:10.3390/nu16244318 · Cited by 16 · see citing works

The thienotriazolodiazepine Ro 11‐1464 increases plasma apoA‐I and promotes reverse cholesterol transport in human apoA‐I transgenic mice

Zanotti, I., Maugeais, C., Pedrelli, M., Gomaraschi, M., Salgam, P., Calabresi, L., Bernini, F., & Kempen, H. J. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01376.x · Cited by 13 · see citing works

Effects ofω-3 Polyunsaturated Fatty Acids on Plasma Proteome in Rett Syndrome

Felice, C. D., Cortelazzo, A., Signorini, C., Guerranti, R., Leoncini, S., Pecorelli, A., Durand, T., Galano, J., Oger, C., Zollo, G., et al. (2013) · Mediators of Inflammation · doi:10.1155/2013/723269 · Cited by 13 · see citing works

The effect of Omega-3 fatty acids on serum paraoxonase activity, vitamins A, E, and C in type 2 diabetic patients.

Kouchak, A., Djalali, M., Eshraghian, M., Saedisomeolia, A., Djazayery, A., & Hajianfar, H. (2011) · PubMed Central · Cited by 12 · see citing works

Allyl isothiocyanate as a potential inducer of paraoxonase‐1 ‐ studies in cultured hepatocytes and in mice

Schrader, C., Graeser, A.-C., Huebbe, P., Wagner, A. E., & Rimbach, G. H. (2011) · IUBMB Life · doi:10.1002/iub.587 · Cited by 12 · see citing works

Intake levels of dietary polyunsaturated fatty acids modify the association between the genetic variation in PCSK5 and HDL cholesterol

Jang, H. B., Hwang, J., Park, J. E., Oh, J. H., Ahn, Y., Kang, J., Park, K., Han, B., Kim, B., Park, S. I., et al. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102670 · Cited by 11 · see citing works

MEDICAL AND AGRICULTURAL ASPECTS OF LIPIDS

Harwood, M. E. J. L., Ramji, D., Evans, M., Dodds, P., & Murphy, D. (2007) · CRC Press eBooks · doi:10.1201/9781420009675-15 · Cited by 14 · see citing works

Effects of Iron Supplementation With and Without Docosahexaenoic Acid on the Cardiovascular Disease Risk Based on Paraoxonase-1, hs-CRP, and ApoB/ApoA-I Ratio in Women with Iron Deficiency Anemia

Shidfar, F., Amani, S., Vafa, M., Shekarriz, R., Hosseini, S., Shidfar, S., Eshraghian, M., & Mousavi, S. N. (2015) · Biological Trace Element Research · doi:10.1007/s12011-015-0383-7 · Cited by 10 · see citing works

Administration of eicosapentaenoic acid may alter high-density lipoprotein heterogeneity in statin-treated patients with stable coronary artery disease: A 6-month randomized trial

Tani, S., Matsuo, R., Yagi, T., & Matsumoto, N. (2019) · Journal of Cardiology · doi:10.1016/j.jjcc.2019.08.011 · Cited by 10 · see citing works

Elevated high-density lipoprotein triglycerides increase atherosclerotic risk

Liu, W., Chen, S., Yang, C., Lei, F., Huang, X., Zhang, X., Sun, T., Lin, L., Wang, C., Cao, Y., et al. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100791 · Cited by 8 · see citing works

Omega-3 fatty acid supplementation for the prevention of arrhythmias

Chung, M. K. (2008) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-008-0031-z · Cited by 8 · see citing works

O Papel dos Ácidos Gordos na Nutrição Humana e Desenvolvimentos Sobre o Modo Como Influenciam a Saúde

Guiné, R. P. F., & Henriques, F. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 7 · see citing works

The Use of Fish Oil Supplements in Clinical Practice: A Review

Guilliams, T. G. (2005) · Cited by 7 · see citing works

Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA-I Metabolism: A Systematic Overview

Smolders, L., Plat, J., & Mensink, R. P. (2017) · Journal of Nutrition and Metabolism · doi:10.1155/2017/5415921 · Cited by 7 · see citing works

Administration of eicosapentaenoic acid may alter lipoprotein particle heterogeneity in statin-treated patients with stable coronary artery disease: A pilot 6-month randomized study

Tani, S., Yagi, T., Matsuo, R., Kawauchi, K., Atsumi, W., Matsumoto, N., & Okumura, Y. (2020) · Journal of Cardiology · doi:10.1016/j.jjcc.2020.06.006 · Cited by 7 · see citing works

High-Density Lipoprotein Cholesterol

Gotto, P. P. T. A. A. M. (2013) · CRC Press eBooks · doi:10.3109/9781420019667-14 · Cited by 7 · see citing works

Omega-3 Fatty Acid Ethyl Esters (Omacor®) For The Treatment Of Hypertriglyceridemia

Bhatnagar, D., & Hussain, F. (2007) · Future Lipidology · doi:10.2217/17460875.2.3.263 · Cited by 6 · see citing works

Paraoxonase 1 serum activity in women: the effects of menopause, the C(-107)T polymorphism and food intake

Ritta, M. C., Baldez, A. M., Oliveira, I. O., Garcia, D. N., Souza, P. S., Andrade, K. R. D. S., Valle, S. C., Pieniz, S., Barros, C. C., Masternak, M. M., et al. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000130 · Cited by 5 · see citing works

Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses

Calabresi, L., Donati, D., Pazzucconi, F., Sirtori, C. R., & Franceschini, G. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00267-1 · Cited by 104 · see citing works

The effects of ω3 and ω6 fatty acid-enriched diets on plasma lipoproteins and apoproteins in familial combined hyperlipidemia

Failor, R. A., Childs, M. T., & Bierman, E. L. (1988) · Metabolism · doi:10.1016/0026-0495(88)90061-3 · Cited by 53 · see citing works

Effects of fish oil concentrate on lipoproteins and apolipoproteins in familial combined hyperlipidemia

Tat�, F., Keller, C., & Wolfram, G. (1993) · Journal of Molecular Medicine · doi:10.1007/bf00184734 · Cited by 14 · see citing works

Effect of N-3 Polyunsaturated Fatty Acids on Lipid Composition in Familial Hypercholesterolemia: A Randomized Crossover Trial

Hande, L. N., Kjellmo, C. A., Pettersen, K., Ljunggren, S., Karlsson, H., Cederbrant, K., Marcusson‐Ståhl, M., Hovland, A., & Lappegård, K. T. (2022) · Biomedicines · doi:10.3390/biomedicines10081809 · Cited by 3 · see citing works

ω-3 Fatty Acid Ethyl Esters Diminish Postprandial Lipemia in Familial Hypercholesterolemia

Chan, D. C., Pang, J., Barrett, P. H. R., SULLIVAN, D. R., Burnett, J. R., BOCKXMEER, F. M. V., & Watts, G. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2217 · Cited by 34 · see citing works